2-(pýridín-2-ýlamínó)-pýridó[2,3-d]pýrimidín-7-ón

The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (cdk4).

Saved in:
Bibliographic Details
Main Authors JOSEPH THOMAS REPINE, PETER LAURENCE TOOGOOD, RICHARD JOHN BOOTH, MARK ROBERT BARVIAN, HAIRONG ZHOU, SCOTT NORMAN VANDERWEL, DEREK JAMES SHEEHAN, JOHN QUIN III
Format Patent
LanguageIcelandic
Published 16.06.2004
Edition7
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (cdk4).
Bibliography:Application Number: IS20040007323